Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

pfizer europe ma eeig - glasdegib maleate - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - pregabalinum inn - hart hylki - 300 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - tramadolum hýdróklóríð - forðatafla - 200 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - eplerenonum inn - filmuhúðuð tafla - 50 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka d.d. novo mesto* - simvastatinum inn; ezetimibe - tafla - 10 mg/ 40 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 250 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - prasugrelum inn - filmuhúðuð tafla - 10 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - pregabalinum inn - hart hylki - 225 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - rasagilinum tartrat - tafla - 1 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

krka d.d. novo mesto* - sitagliptinum inn - filmuhúðuð tafla - 100 mg